國立虎尾科技大學 |

Targeting Oral Cancer

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Targeting Oral Cancer/ edited by Andrew Fribley.
other author:	Fribley, Andrew.
Description:	X, 302 p. 38 illus., 2 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Dentistry. -
Online resource:	https://doi.org/10.1007/978-3-319-27647-2
ISBN:	9783319276472

Targeting Oral Cancer
Targeting Oral Cancer[electronic resource] /edited by Andrew Fribley. - 1st ed. 2016. - X, 302 p. 38 illus., 2 illus. in color.online resource.

Epidemiology and Management: Epidemiology -- Emerging Role of HPV -- Management of Oral Cancer. Development and Biomarkers: Molecular Progression and Signaling -- Stem Cells and Tumor Development -- Prognostic/Predictive Biomarkers -- EIF4e as Biomarker and Target. Breaking Developments and New Drug Discovery: Current Clinical Trials -- Emerging Drug Targets -- Targeting the UPR -- Targeting Meditators of Coagulation -- Resveratrol Pre-Sensitizing -- Academic High Throughput Drug Discovery.

This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity. The text is organized into three sections covering epidemiology and management, cancer development and biomarkers, and breaking developments and novel approaches for drug discovery. The first section includes discussion of the emerging role of human papillomavirus in oral cancer and explains the surgical, chemotherapy, and radiation approaches to treatment. Aspects such as molecular progression and signaling, the role of cancer stem cells in tumor development, and the value of various biomarkers are then examined. The final section is devoted to the latest advances and covers, among other topics, current clinical trials, emerging drug targets, and targeting of the unfolded protein response and of mediators of coagulation. Recent decades have witnessed a significant increase in the number of deaths worldwide from cancers of the oral cavity, pharynx, and oropharynx. Targeting Oral Cancer will be an excellent resource for practitioners and researchers and will hopefully assist in the urgent quest to improve screening and prevention, diagnosis, and treatment approaches.

ISBN: 9783319276472

Standard No.: 10.1007/978-3-319-27647-2doiSubjects--Topical Terms:

674038
Dentistry.

LC Class. No.: RK1-715

Dewey Class. No.: 617.6

Targeting Oral Cancer
LDR:03143nam a22003975i 4500 001 976782
003 DE-He213
005 20200630090800.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319276472 $9 978-3-319-27647-2
024 7 $a 10.1007/978-3-319-27647-2 $2 doi
035 $a 978-3-319-27647-2
050 4 $a RK1-715
072 7 $a MMD $2 bicssc
072 7 $a MED016000 $2 bisacsh
072 7 $a MKE $2 thema
082 0 4 $a 617.6 $2 23
245 1 0 $a Targeting Oral Cancer $h [electronic resource] / $c edited by Andrew Fribley.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a X, 302 p. 38 illus., 2 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Epidemiology and Management: Epidemiology -- Emerging Role of HPV -- Management of Oral Cancer. Development and Biomarkers: Molecular Progression and Signaling -- Stem Cells and Tumor Development -- Prognostic/Predictive Biomarkers -- EIF4e as Biomarker and Target. Breaking Developments and New Drug Discovery: Current Clinical Trials -- Emerging Drug Targets -- Targeting the UPR -- Targeting Meditators of Coagulation -- Resveratrol Pre-Sensitizing -- Academic High Throughput Drug Discovery.
520 $a This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity. The text is organized into three sections covering epidemiology and management, cancer development and biomarkers, and breaking developments and novel approaches for drug discovery. The first section includes discussion of the emerging role of human papillomavirus in oral cancer and explains the surgical, chemotherapy, and radiation approaches to treatment. Aspects such as molecular progression and signaling, the role of cancer stem cells in tumor development, and the value of various biomarkers are then examined. The final section is devoted to the latest advances and covers, among other topics, current clinical trials, emerging drug targets, and targeting of the unfolded protein response and of mediators of coagulation. Recent decades have witnessed a significant increase in the number of deaths worldwide from cancers of the oral cavity, pharynx, and oropharynx. Targeting Oral Cancer will be an excellent resource for practitioners and researchers and will hopefully assist in the urgent quest to improve screening and prevention, diagnosis, and treatment approaches.
650 0 $a Dentistry. $3 674038
650 0 $a Oncology . $3 1253469
650 0 $a Oral surgery. $3 1254067
650 0 $a Maxillofacial surgery. $3 1254068
650 2 4 $a Oncology. $3 593951
650 2 4 $a Oral and Maxillofacial Surgery. $3 674039
700 1 $a Fribley, Andrew. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1270707
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319276458
776 0 8 $i Printed edition: $z 9783319276465
776 0 8 $i Printed edition: $z 9783319801926
856 4 0 $u https://doi.org/10.1007/978-3-319-27647-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)